These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9468201)

  • 21. Incidence, management, and outcome of coronary artery perforation during percutaneous coronary intervention.
    Gruberg L; Pinnow E; Flood R; Bonnet Y; Tebeica M; Waksman R; Satler LF; Pichard AD; Kent KM; Leon MB; Lindsay J
    Am J Cardiol; 2000 Sep; 86(6):680-2, A8. PubMed ID: 10980224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. One-year follow-up in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT I).
    Elliott JM; Berdan LG; Holmes DR; Isner JM; King SB; Keeler GP; Kearney M; Califf RM; Topol EJ
    Circulation; 1995 Apr; 91(8):2158-66. PubMed ID: 7697844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravascular ultrasound predictors of subacute vessel closure after balloon angioplasty or atherectomy.
    Cheneau E; Mintz GS; Leborgne L; Kotani J; Satler LF; Ajani AE; Weissman NJ; Waksman R; Pichard AD
    J Invasive Cardiol; 2004 Oct; 16(10):572-4. PubMed ID: 15505353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of costs of new atherectomy devices and balloon angioplasty for coronary artery disease.
    Guzman LA; Simpfendorfer C; Fix J; Franco I; Whitlow PL
    Am J Cardiol; 1994 Jul; 74(1):22-5. PubMed ID: 8017300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced distal embolization with transluminal extraction atherectomy compared to balloon angioplasty for saphenous vein graft disease.
    Misumi K; Matthews RV; Sun GW; Mayeda G; Burstein S; Shook TL
    Cathet Cardiovasc Diagn; 1996 Nov; 39(3):246-51. PubMed ID: 8933966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Current approaches to restenosis after coronary interventions].
    Magosaki N; Tsurumi Y; Hosoda S
    Nihon Rinsho; 1998 Jan; 56(1):242-8. PubMed ID: 9465696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The illusive ostial and proximal LAD.
    Linnemeier TJ
    Catheter Cardiovasc Interv; 2000 Mar; 49(3):272-3. PubMed ID: 10700057
    [No Abstract]   [Full Text] [Related]  

  • 28. Randomized comparison of angioplasty of complex coronary lesions at a single center. Excimer Laser, Rotational Atherectomy, and Balloon Angioplasty Comparison (ERBAC) Study.
    Reifart N; Vandormael M; Krajcar M; Göhring S; Preusler W; Schwarz F; Störger H; Hofmann M; Klöpper J; Müller S; Haase J
    Circulation; 1997 Jul; 96(1):91-8. PubMed ID: 9236422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Directional coronary atherectomy (DCA)].
    Fujii K; Minamino T
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):916-20. PubMed ID: 12436638
    [No Abstract]   [Full Text] [Related]  

  • 30. Matching to guide the design and predict the outcome of randomized atherectomy trials.
    Umans VA; Keane D; Quaedvlieg P; Serruys PW
    Am Heart J; 1995 Nov; 130(5):1135-43. PubMed ID: 7484751
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of dilatation mechanism and long-term vessel remodeling between directional coronary atherectomy and balloon angioplasty assessed by volumetric intravascular ultrasound.
    Suzumura H; Hosokawa H; Suzuki T; Fukutomi T; Ito S; Itoh M
    J Invasive Cardiol; 2002 Jun; 14(6):315-20. PubMed ID: 12042623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [PTCA or alternative techniques? Balloon angioplasty remains dominant].
    Reifart N
    Z Kardiol; 1995; 84 Suppl 2():43-52. PubMed ID: 7571782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty.
    EPIC Investigators
    N Engl J Med; 1994 Apr; 330(14):956-61. PubMed ID: 8121459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. The CAVEAT Study Group.
    Topol EJ; Leya F; Pinkerton CA; Whitlow PL; Hofling B; Simonton CA; Masden RR; Serruys PW; Leon MB; Williams DO
    N Engl J Med; 1993 Jul; 329(4):221-7. PubMed ID: 8316266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Directional coronary atherectomy for coronary artery spasm refractory to medical therapy.
    Hilton TC; Blackshear JL; Utset B; Kern MJ
    Clin Cardiol; 1996 Aug; 19(8):662-4. PubMed ID: 8864341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Issues in evaluating new devices: coronary atherectomy/rotational ablation.
    Mooney MR; Mooney JF
    J Invasive Cardiol; 1993 Mar; 5(2):79-84. PubMed ID: 10148629
    [No Abstract]   [Full Text] [Related]  

  • 37. The mechanism of directional coronary atherectomy.
    Umans VA; Haine E; Renkin J; de Feyter PJ; Wijns W; Serruys PW
    Eur Heart J; 1993 Apr; 14(4):505-10. PubMed ID: 8472714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interventional techniques for the management of coronary artery lesions: an update.
    de Feyter PJ; MacLeod DC; Foley D; de Jaegere PP; Serruys PW
    Clin Cardiol; 1993 Aug; 16(8):586-93. PubMed ID: 8370189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Observational versus randomized medical device testing before and after market approval--the atherectomy-versus-angioplasty controversy.
    Omoigui NA; Topol EJ
    Control Clin Trials; 1995 Jun; 16(3):143-9. PubMed ID: 7796597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of the Jailed-Balloon Technique in Percutaneous Intervention for Severe Coronary Perforation Involving Left Main Bifurcation.
    Takagi K; Furui K; Morishima I; Tsuboi H
    JACC Cardiovasc Interv; 2017 Nov; 10(22):e209-e211. PubMed ID: 29102580
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.